(Q44205715)

30 November 2017

title

Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controls (English)

1 reference

30 November 2017

0 references

1 reference

2

1 reference

30 November 2017

Christoph Heesen

1

1 reference

30 November 2017

Justus Sondermann

series ordinal

3

1 reference

30 November 2017

Wiebcke Tessmer

series ordinal

4

1 reference

30 November 2017

Karl-Heinz Schulz

series ordinal

5

1 reference

30 November 2017

publication date

1 November 2002

1 reference

Journal of Neuroimmunology

30 November 2017

published in

1 reference

30 November 2017

volume

132

1 reference

30 November 2017

issue

1-2

1 reference

30 November 2017

page(s)

189-195

1 reference

IL-10 fails to abrogate experimental autoimmune encephalomyelitis

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Disappearance of beta2-adrenergic receptors on astrocytes in canine distemper encephalitis: possible implications for the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Increased release of interleukin-12p40 in MS: association with intracerebral inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Interleukin-12 is detectable in sera of patients with multiple sclerosis - association with chronic progressive disease course?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Sympathetic skin responses are decreased and lymphocyte beta-adrenergic receptors are increased in progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Splenic noradrenergic and adrenocortical responses during the preclinical and clinical stages of adoptively transferred experimental autoimmune encephalomyelitis (EAE)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Beta-adrenoceptor control of immune function in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Problems with rating scales for multiple sclerosis: a novel approach--the CAMBS score

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Altered cytokine production in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Norepinephrine, the beta-adrenergic receptor, and immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

IFN-gamma production by Th1 cells generated from naive CD4+ T cells exposed to norepinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2- and beta-adrenoceptors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

Increased expression of high affinity IL-2 receptors and beta-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900322-3

7 January 2021

10.1016/S0165-5728(02)00322-3

Identifiers

DOI

1 reference

30 November 2017

1 reference